Cassava Sciences Inc.
SAVA | NASDAQ
$1.32
+$0.03 (+2.33%)
At close: May 22, 2026, 12:35 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 936K | 1.13M | 89.42M | 68.03M | 534K | 3.05M |
Gross Profit | -936K | -1.13M | -89.42M | -68.03M | -534K | -3.05M |
Operating Income | -95.39M | -141.45M | -105.96M | -80.02M | -32.87M | -6.45M |
Interest Income | 4.62M | 8.51M | 7.83M | 2.78M | 49K | 112K |
Pretax Income | -90.97M | -24.34M | -97.22M | -76.25M | -32.39M | -6.33M |
Net Income | -90.97M | -24.34M | -97.22M | -76.25M | -32.39M | -6.33M |
Selling & General & Admin | 68.8M | 71.81M | 16.53M | 11.99M | 8.06M | 3.74M |
Research & Development | 26.59M | 69.64M | 89.42M | 68.93M | 24.81M | 7.25M |
Other Expenses | -936K | -69.64M | -89.42M | -68.93M | -28.71M | -7.6M |
Operating Expenses | 94.45M | 141.45M | 16.53M | 11.99M | 32.87M | 3.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 95.39M | 141.45M | 105.96M | 80.02M | 32.87M | 6.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 48.3M | 46.33M | 41.93M | 40.2M | 39.41M | 26.11M |
Shares Outstanding (Diluted) | 48.3M | 46.6M | 41.93M | 40.2M | 39.41M | 26.11M |
EPS (Basic) | -1.88 | -0.53 | -2.32 | -1.80 | -0.81 | -0.22 |
EPS (Diluted) | -1.88 | -0.52 | -2.32 | -1.80 | -0.81 | -0.22 |
EBITDA | -94.45M | -141.15M | -104.43M | -78.72M | -32.33M | -6.77M |
EBIT | -95.39M | -142.28M | -105.96M | -80.02M | -32.87M | -6.79M |
Depreciation & Amortization | 936K | 1.13M | 1.53M | 1.3M | 534K | 22K |
Add to Watchlist
Select watchlists to add or remove SAVA